Tuesday, November 5, 2024
HomeTagsRetinal diseases

retinal diseases

Glaukos Announces FDA Acceptance of NDA Submission for iDose TR

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics